Litigation

Dr. Falk Pharma GmbH v. Ellodi Pharmaceuticals, L.P.

Pending

PGR2025-00086

Auto-generating section 1 of 4: Case overview & background

Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.

Filed
2025-09-19

Patents at issue (1)

Plaintiffs (1)

Defendants (1)

Summary

Post-Grant Review (PGR) filed by petitioner Dr. Falk Pharma GmbH, challenging the validity of claims 1-34 of the '598 patent. The grounds for the challenge include lack of written description and anticipation.

Case overview & background

Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Key legal developments & outcome

Major rulings, motions, claim construction, settlements, and the present posture or final disposition.

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Plaintiff representatives

Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Defendant representatives

Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).